跳至主要内容
临床试验/NCT01891604
NCT01891604撤回不适用

Study the Safety and Efficacy of Probiotics Use in Premature Infants

University of Manitoba0 个研究点开始时间: 2013年7月3日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Calprotectin will be used to determine the effect for probiotics

研究概览

简要总结

Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm infants' health, and may also play a role in reducing NEC and associated morbidity.

研究设计

研究类型
Interventional
干预模型
Parallel

入排标准

年龄范围
— 至 2 Days(Child)
性别
All
接受健康志愿者

入选标准

  • born with weight<1500 g
  • hospitalized within 48 hours after birth

排除标准

  • present with evidence or suspicion of congenital intestinal obstruction
  • perforation
  • gastroschisis
  • large omphalocele
  • congenital diaphragmatic hernia
  • major congenital heart defects

结局指标

主要结局

Calprotectin will be used to determine the effect for probiotics

时间窗: day1 and day30 of the observation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. James Friel

Professor

University of Manitoba

相似试验